Brief: Mizuho Medy obtains marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination
22/02/2018 02:43
Feb 22 (Reuters) - Mizuho Medy Co Ltd 4595.T
* Says it obtained the marketing and manufacture approval of
mycoplasma nucleic acid kit for genetic POCT examination in
Japan on Feb. 19
Source text in Japanese:https://goo.gl/LVabQk
Further company coverage: 4595.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))